Call for Abstract


calls Oral and Posters Presentations



You are invited to submit an abstract of original research related to the Conference Topics to be considered as:

  • Strolling poster session
  • Oral Presentation



The main topic areas have been determined and reflect key questions to be discussed:

  • Aetiology & Physiopathology (including inflammation, genomics, etc.)
  • AATD – Alpha-1 Antitrypsin Deficiency
  • Comorbidities and Overlaps (including CF, COPD, etc.)
  • Epidemiology & Registries
  • Exacerbations
  • Imaging
  • NTM
  • Infections (including ABP, Pseudomonas, Hemophilus, etc.)
  • PCD – Primary Ciliary Dyskinesia
  • Precision medicine
  • Respiratory Physiotherapy & Airways Clearance
  • Treatments and New Drugs


the concept

Accepted abstract presenters will have the opportunity to either:
  • Present your work in the main auditorium with Q&A from internationals experts. Further details on timing and schedule of the lectures will be shared in due time.
  • Display your poster in front of the entire audience and have the opportunity to briefly present your research to the Scientific Committee and to reply to participants’ questions during the dedicated strolling poster sessions. Further details on timing and schedule of the sessions will be shared in due time.
All presenters will receive the personal feedback of the Scientific Committee of the Conference who will provide useful advice for the development of the winners’ career as researchers and international conference faculty;



In order to participate in the selection process, please submit before April 10th, 2024.

  • Select the category “oral presentation” or “posters”
  • select the topic among the list, follow the instructions and complete your submission according to the rules.
  • State the conflict-of-interest disclosures for each author at the end of the submitted abstract (If there are no conflict of interest, it should be stated as well).


selection criteria

The main selecting criteria will be the relevancy and scientific value of the abstract presented, evaluated by the Scientific Committee of the Conference. The choice will be made at the Committee discretion.



Notifications to submitters will be sent by the end of April 2024.

Abstracts will be accepted as oral presentations or posters (please indicate your preference when submitting the abstract online).

Submission is closed

WBNC 2022 poster award winners

Mengyu Li

Mengyu Li is currently a first year PhD student in School of Pharmacy at the University of Sydney, working under Professor Hak-Kim Chan. Her research is focused on the formulation of phage cocktail. She is particularly interested in formulation of an inhalable Pseudomonas Phage Cocktail Powder for respiratory infections. Her other major research interest is the effect of phage cocktail targeting on different receptors on the surface of bacteria. She can be contacted at:

Nona Rovira Ribalta

Nona Rovira – Ribalta is a respiratory physical therapist working on research in the Hospital Clinic of Barcelona. She is also an assistant professor in Physiotherapy degree in EUSES Girona college. The group where she takes part is focused on applied research in respiratory diseases.  Among the research lines that the group works on, she centers her practice on bronchiectasis. In particular, she is in charge of the patients’ enrollment in clinical studies as well as conducting visits and follow-ups. Moreover, she is implicated in research projects that are currently ongoing about other respiratory diseases, including VAP and COVID-19.

She is genuinely captivated by the understanding of microbiological patterns in bronchiectasis patients.

Letizia Traversi

Letizia Traversi is a Respiratory Physician. After specializing in Pneumology in Varese (Italy), she enrolled in a PhD program at the Vall d’Hebron Institut de Recerca (VHIR) of Barcelona (Spain). Her main research and clinical interests include respiratory infection, bronchiectasis, cystic fibrosis, immunodeficiencies and PCD, with a special focus on airways comorbidities in such diseases.

Tjeerd van der Veer

Tjeerd van der Veer is a pulmonologist and clinical researcher working at the Erasmus MC academic centre, Rotterdam, the Netherlands with a focus on respiratory infectious disease. Tjeerd has a keen interest in bronchiectasis as a cause and consequence of pulmonary infections. Tjeerd is currently writing a PhD thesis on the interaction between bronchiectasis and asthma as well as automated methods for bronchiectasis detection and quantification on chest CT as part of the EMBARC collaboration. Tjeerd greatly enjoyed the 5th World Bronchiectasis and NTM Conference in Prague and wants to thank the committee for the honour of being elected best poster presentation!

Sanne Zweijpfenning

Sanne Maria Henriëtte Zweijpfenning is a medical doctor specializing to become a pulmonologist. In addition to this she is a PhD student at Radboud University Medical Center Nijmegen in The Netherlands. Her PhD is about the improvement of the treatment of non-tuberculous mycobacteria, consisting of various mainly clinical studies. Her most recent study compares clofazimine as an alternative to rifampicin in the treatment of Mycobacterium avium complex pulmonary disease, in a randomized clinical trial, yielding comparable outcomes.